Dr. Mok is the Chief of Rheumatology in the Department of Medicine, Tuen Mun Hospital and Center for Assessment and Treatment of Rheumatic Diseases at Pok Oi Hospital, Hong Kong. He is also the President of the Hong Kong Society of Rheumatology. Dr. Mok is the principal investigator of a number of clinical trials of novel biological agents in systemic lupus erythematosus, rheumatoid arthritis and glucocorticoid-induced osteoporosis. In addition, Dr. Mok is the core editorial member of a number of international journals in Rheumatology and is the adhoc reviewer of more than 50 Rheumatology and General Medical Journals. He has reviewed more than 279 clinical papers and 6 grant applications. Dr. Mok is the Chief of Rheumatology in the Department of Medicine, Tuen Mun Hospital and Center for Assessment and Treatment of Rheumatic Diseases at Pok Oi Hospital, Hong Kong. He is also the President of the Hong Kong Society of Rheumatology. Dr. Mok is the principal investigator of a number of clinical trials of novel biological agents in systemic lupus erythematosus, rheumatoid arthritis and glucocorticoid-induced osteoporosis. In addition, Dr. Mok is the core editorial member of a number of international journals in Rheumatology and is the adhoc reviewer of more than 50 Rheumatology and General Medical Journals. He has reviewed more than 279 clinical papers and 6 grant applications.

Rheumatology and General Medicine